Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,555 USD | -0,98% | -15,58% | -45,16% |
Omzet 2024 * | 34,3 mln. 32,14 mln. | Omzet 2025 * | 24,82 mln. 23,26 mln. | Marktkapitalisatie | 456 mln. 428 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -206 mln. -193 mln. | Nettowinst (verlies) 2025 * | -242 mln. -227 mln. | EV/omzet 2024 * | 5,95 x |
Nettoliquiditeiten 2024 * | 252 mln. 237 mln. | Nettoliquiditeiten 2025 * | 95 mln. 89,03 mln. | EV/omzet 2025 * | 14,6 x |
K/w-verhouding 2024 * |
-2,26
x | K/w-verhouding 2025 * |
-2,17
x | Werknemers | 265 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,68% |
Recentste transcriptie over Editas Medicine, Inc.
1 dag | -0,98% | ||
1 week | -15,58% | ||
Lopende maand | -25,13% | ||
1 maand | -28,04% | ||
3 maanden | -32,01% | ||
6 maanden | -15,83% | ||
Lopend jaar | -45,16% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gilmore O’Neill
CEO | Chief Executive Officer | 59 | 01-06-22 |
Erick Lucera
DFI | Director of Finance/CFO | 57 | 17-05-23 |
Linda Burkly
CTO | Chief Tech/Sci/R&D Officer | - | 24-07-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Emma Reeve
CHM | Chairman | 63 | 03-09-21 |
David Scadden
BRD | Director/Board Member | 71 | 06-02-19 |
Akshay Vaishnaw
BRD | Director/Board Member | 61 | 28-07-16 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
4.83% | 2 M€ | -25,75% | ||
0.13% | 2 M€ | -.--% | ||
0.09% | 0 M€ | 0,00% | - | |
0.06% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 5,55 | -1,07% | 1 715 551 |
17-04-24 | 5,61 | -4,10% | 1 910 234 |
16-04-24 | 5,85 | -3,78% | 1 338 818 |
15-04-24 | 6,08 | -2,09% | 1 771 828 |
12-04-24 | 6,21 | -5,62% | 2 024 621 |
uitgestelde koers Nasdaq, 18 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-45,16% | 456 mln. | |
-1,82% | 41,35 mld. | |
+42,61% | 40,38 mld. | |
+2,56% | 39,05 mld. | |
-12,11% | 26,67 mld. | |
+3,09% | 24,07 mld. | |
-24,16% | 18,36 mld. | |
+22,12% | 11,6 mld. | |
-3,74% | 11,68 mld. | |
+7,75% | 11,15 mld. |